Leo Pharma Sues Perrigo Israel Over Generic Taclonex
Leo Pharma A/S has sued generic-drug maker Perrigo Israel Pharmaceuticals Ltd. to block it from selling its own version of the Danish company's Taclonex ointment, used to treat the skin disease...To view the full article, register now.
Already a subscriber? Click here to view full article